Crohn's disease
Wellcome Sanger Institute, Open Targets Fund Inflammatory Bowel Disease Biomarker Study
Researchers will analyze multiomic and clinical data from 1,000 patients with IBD recruited from seven participating hospitals in the UK.
Inflammatory Bowel Disease Genetics Understanding Expands With East Asian Analyses
A genome-wide association study and meta-analysis of tens of thousands of East Asian participants led to new genetic contributors to Crohn's disease and ulcerative colitis.
The CDPath prognostic tool gives Crohn's patients risk scores for serious complications within three years, so they can make more informed treatment decisions.
The Seattle-based company recently published immune repertoire data showing the potential of T-cell receptor profiling in IBD diagnostics.
Coral Genomics, Crohn's & Colitis Foundation Partner on Study of IBD Treatment Response
San Francisco-based Coral will study up to 1,000 patients in an IBD cohort as it develops a test to predict patient response to treatment.
Nov 11, 2020
Jul 13, 2020
Mar 5, 2020
Feb 26, 2019